WebDisclosure WebDisclosure
Basculer en Français
10713 Companies
229446 Keywords
158044 Articles
121874 Press releases
Headlines Articles Press releases CAGE Bio Inc. Remove
  1. Home
  2. Companies
  3. CAGE Bio Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/09/2025 at 21:05, 1 year 6 months ago

    CAGE Bio Launches Phase 2b Trial for Atopic Dermatitis Treatment CGB-500

    Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Ionic Liquid Technology
  • BRIEF

    published on 01/09/2025 at 21:05, 1 year 6 months ago

    CAGE Bio lance un essai de phase 2b pour le traitement de la dermatite atopique CGB-500

    CGB-500 Biographie De CAGE Essai De Phase 2b Dermatite Atopique Technologie Des Liquides Ioniques
  • PRESS RELEASE

    published on 01/09/2025 at 21:00, 1 year 6 months ago

    CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis

    CAGE Bio initiates Phase 2b trial for CGB-500, a topical JAK inhibitor ointment for atopic dermatitis. High efficacy, low side-effects. Improving patient outcomes
    Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Topical Therapy
    Logo of CAGE Bio Inc.
  • PRESS RELEASE

    published on 08/03/2023 at 16:45, 2 years 11 months ago

    CAGE Bio Announces Positive Topline Results From its Double-Blind Phase 2 Study Evaluating an Ionic Liquid formulation of 1% Tofacitinib In Patients with Atopic Dermatitis

    Logo of CAGE Bio Inc.
Accesswire
  • Published on 07/14/2026 at 01:45, 14 minutes ago

    Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility

  • Published on 07/14/2026 at 00:01, 1 hour 58 minutes ago

    Captor Capital Announces Delay in its Annual Filings

  • Published on 07/13/2026 at 23:10, 2 hours 49 minutes ago

    Galaxy Ventures Inc. Announces Director Resignation

  • Published on 07/13/2026 at 21:35, 4 hours 24 minutes ago

    ATHA Energy Announces Corporate Activities Update

  • Published on 07/13/2026 at 20:00, 5 hours 59 minutes ago

    IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE
EQS Group
  • Published on 07/13/2026 at 22:30, 3 hours 28 minutes ago

    Half-year 2026 Results Media and Investor Conference Call and Webcast

  • Published on 07/13/2026 at 21:20, 4 hours 38 minutes ago

    Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

  • Published on 07/13/2026 at 21:17, 4 hours 41 minutes ago

    EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

  • Published on 07/13/2026 at 20:48, 5 hours 10 minutes ago

    EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026

  • Published on 07/13/2026 at 20:23, 5 hours 35 minutes ago

    EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations

View all EQS
Les Echos
  • Published on 07/13/2026 at 18:00, 7 hours 59 minutes ago

    CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense

  • Published on 07/13/2026 at 18:00, 7 hours 59 minutes ago

    PR Icade - Icade regains full ownership of the Eqho Tower in La Défense

  • Published on 07/13/2026 at 18:00, 7 hours 59 minutes ago

    THERMADOR GROUPE : 2026 half-year turnover

  • Published on 07/13/2026 at 18:00, 7 hours 59 minutes ago

    THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026

  • Published on 07/13/2026 at 17:45, 8 hours 14 minutes ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy